Spun out by researchers at the University of Melbourne, brain-computer interface company Synchron this week became the first company to begin clinical trials in the United States, ahead of Elon Musk’s Neuralink. Synchron is trialing its Stentrode implant which aims to allow severely paralysed patients to control digital devices using their brain. The early feasibility…

The post Melbourne Uni spin out beats Elon Musk to US clinical trials appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.